Alnylam Pharmaceuticals, Inc.

JANE STREET GROUP, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

311,288

Value ($000)

123,784

Weight

0.1%

2014 Q1 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	123,784	0.1%	311,288	12/31/2025
2025 Q3	11/14/2025	437,190	0.5%	958,750	9/30/2025
2025 Q2	8/14/2025	7,453	0.0%	22,856	6/30/2025
2025 Q1	5/19/2025	26,611	0.0%	98,551	3/31/2025
2024 Q4	2/14/2025	37,799	0.1%	160,637	12/31/2024
2024 Q3	11/15/2024	37,481	0.1%	136,281	9/30/2024
2024 Q2	8/15/2024	33,898	0.0%	139,497	6/30/2024
2024 Q1	5/16/2024	24,501	0.0%	163,938	3/31/2024
2023 Q4	2/15/2024	18,636	0.0%	97,363	12/31/2023
2023 Q3	11/15/2023	9,747	0.0%	55,036	9/30/2023
2023 Q2	8/14/2023	6,960	0.0%	36,642	6/30/2023
2023 Q1	5/16/2023	14,597	0.0%	72,869	3/31/2023
2022 Q4	2/15/2023	28,275	0.1%	118,976	12/31/2022
2022 Q3	11/15/2022	54,642	0.1%	272,989	9/30/2022
2022 Q2	8/16/2022	18,939	0.0%	129,852	6/30/2022
2022 Q1	5/17/2022	11,032	0.0%	67,563	3/31/2022
2021 Q4	2/15/2022	19,664	0.0%	115,957	12/31/2021
2021 Q3	11/16/2021	2,945	0.0%	15,602	9/30/2021
2021 Q2	8/16/2021	10,155	0.0%	59,901	6/30/2021
2021 Q1	5/18/2021	2,513	0.0%	17,800	3/31/2021
2020 Q4	2/17/2021	895	0.0%	6,882	12/31/2020
2020 Q3	11/17/2020	2,089	0.0%	14,351	9/30/2020
2020 Q2	8/17/2020	11,819	0.0%	79,797	6/30/2020
2020 Q1	5/15/2020	728	0.0%	6,686	3/31/2020
2014 Q1	5/15/2014	1,036	0.0%	15,429	3/31/2014